Cargando…

Monoclonal antibodies to human colon and colorectal carcinoma.

A series of monoclonal antibodies was produced by immunizing mice with fresh carcinoma of the colon and with the cell line HT-29. These antibodies could be classified into 3 different groups: (a) those which were HT-29 specific and reacted with no other cell line or fresh colon carcinoma samples; (b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, C. H., Jones, S. L., Pihl, E., McKenzie, I. F.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1983
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011388/ https://www.ncbi.nlm.nih.gov/pubmed/6342646

Ejemplares similares

Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
por: Bruland, O., et al.
Publicado: (1987)

Immunohistochemical techniques in the early screening of monoclonal antibodies to human colonic epithelium
por: Finan, P. J., et al.
Publicado: (1982)

Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
por: Apostolopoulos, V., et al.
Publicado: (1993)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

The prognostic value of immunoperoxidase staining with monoclonal antibodies NCRC-11 and 3E1.2 in breast cancer.
por: Muir, I. M., et al.
Publicado: (1991)

Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.
por: Nind, A. P., et al.
Publicado: (1975)

A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab
por: McKenzie, Andrew, et al.
Publicado: (2021)

The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma.
por: Robertson, J. F., et al.
Publicado: (1991)

Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies
por: Popa, C, et al.
Publicado: (2012)

Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
por: Durrant, L. G., et al.
Publicado: (1989)

Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen.
por: Price, M. R., et al.
Publicado: (1984)

Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice
Publicado: (1983)

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
por: Stacker, S. A., et al.
Publicado: (1989)

Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.
por: Smedley, H. M., et al.
Publicado: (1983)

Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
por: Natrah, MS, et al.
Publicado: (2012)

Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.
por: Harwood, P. J., et al.
Publicado: (1985)

Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
por: Ben-Aissa, H., et al.
Publicado: (1985)

Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
por: Hwang, Kyusang, et al.
Publicado: (2021)

Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies.
por: Hertzog, P. J., et al.
Publicado: (1991)

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
por: Saha, Nayanendu, et al.
Publicado: (2023)

Monoclonal antibodies against two human lung carcinoma cell lines
por: Brown, D. T., et al.
Publicado: (1982)

Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
por: Yang, Hobin, et al.
Publicado: (2019)

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas
por: Tsang, Kwong yok, et al.
Publicado: (2022)

Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.
por: Ellis, I. O., et al.
Publicado: (1987)

Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.
por: Werkmeister, J. A., et al.
Publicado: (1979)

Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer
por: Song, Xue, et al.
Publicado: (2011)

Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models
por: Li, Guanjie, et al.
Publicado: (2023)

Monoclonal antibody humanness score and its applications
por: Gao, Sean H, et al.
Publicado: (2013)

Human monoclonal antibodies to glioma cells.
por: Sikora, K., et al.
Publicado: (1981)

FAT1: a potential target for monoclonal antibody therapy in colon cancer
por: Pileri, Piero, et al.
Publicado: (2016)

Production and characterisation of a monoclonal antibody (Cx-99) against cervical carcinoma.
por: Yuan, C. C., et al.
Publicado: (1992)

A novel method for making human monoclonal antibodies
por: Fraussen, J., et al.
Publicado: (2010)

Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer
por: Jin, Ke-Tao, et al.
Publicado: (2021)

Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010)

Antiepidermal Growth Factor Receptor Monoclonal Antibodies: Applications in Colorectal Cancer
por: Azizi, Efat, et al.
Publicado: (2012)

Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
por: van Helden, E. J., et al.
Publicado: (2017)

Generation and diversification of recombinant monoclonal antibodies
por: DeLuca, Keith F, et al.
Publicado: (2021)

The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies
por: Baker, David, et al.
Publicado: (2020)

Novel monoclonal antibodies targeting the microtubule-binding domain of human tau
por: Croft, Cara L., et al.
Publicado: (2018)

T10B9 monoclonal antibody: A short-acting nonstimulating monoclonal antibody that spares γδ T-cells and treats and prevents cellular rejection
por: Waid, Thomas H, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_88dau3guipkuiq0l5d39so37uk